Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/1462
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChapple, Lee-Anne Sen_US
dc.contributor.authorFetterplace, Kateen_US
dc.contributor.authorAsrani, Varshaen_US
dc.contributor.authorBurrell, Aidanen_US
dc.contributor.authorCheng, Allen Cen_US
dc.contributor.authorCollins, Peteren_US
dc.contributor.authorDoola, Ra'eesaen_US
dc.contributor.authorFerrie, Suzieen_US
dc.contributor.authorMarshall, Andreaen_US
dc.contributor.authorRidley, Emma Jen_US
dc.date.accessioned2021-08-23T23:58:12Z-
dc.date.available2021-08-23T23:58:12Z-
dc.date.issued2020-09-
dc.identifier.citationChapple LS, Fetterplace K, Asrani V, Burrell A, Cheng AC, Collins P, Doola R, Ferrie S, Marshall AP, Ridley EJ. Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand. Aust Crit Care. 2020 Sep;33(5):399-406. doi: 10.1016/j.aucc.2020.06.002en_US
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/1462-
dc.description.abstractCoronavirus disease 2019 (COVID-19) results from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical features and subsequent medical treatment, combined with the impact of a global pandemic, require specific nutritional therapy in hospitalised adults. This document aims to provide Australian and New Zealand clinicians with guidance on managing critically and acutely unwell adult patients hospitalised with COVID-19. These recommendations were developed using expert consensus, incorporating the documented clinical signs and metabolic processes associated with COVID-19, the literature from other respiratory illnesses, in particular acute respiratory distress syndrome, and published guidelines for medical management of COVID-19 and general nutrition and intensive care. Patients hospitalised with COVID-19 are likely to have preexisting comorbidities, and the ensuing inflammatory response may result in increased metabolic demands, protein catabolism, and poor glycaemic control. Common medical interventions, including deep sedation, early mechanical ventilation, fluid restriction, and management in the prone position, may exacerbate gastrointestinal dysfunction and affect nutritional intake. Nutrition care should be tailored to pandemic capacity, with early gastric feeding commenced using an algorithm to provide nutrition for the first 5-7 days in lower-nutritional-risk patients and individualised care for high-nutritional-risk patients where capacity allows. Indirect calorimetry should be avoided owing to potential aerosole exposure and therefore infection risk to healthcare providers. Use of a volume-controlled, higher-protein enteral formula and gastric residual volume monitoring should be initiated. Careful monitoring, particularly after intensive care unit stay, is required to ensure appropriate nutrition delivery to prevent muscle deconditioning and aid recovery. The infectious nature of SARS-CoV-2 and the expected high volume of patient admissions will require contingency planning to optimise staffing resources including upskilling, ensure adequate nutrition supplies, facilitate remote consultations, and optimise food service management. These guidelines provide recommendations on how to manage the aforementioned aspects when providing nutrition support to patients during the SARS-CoV-2 pandemic.en_US
dc.language.isoenen_US
dc.publisherElsevier Inc.en_US
dc.relation.ispartofAustralian critical care : official journal of the Confederation of Australian Critical Care Nursesen_US
dc.subjectBetacoronavirusen_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirus Infectionsen_US
dc.subjectCritical Illnessen_US
dc.subjectHospitalizationen_US
dc.subjectNutritional Supporten_US
dc.subjectPandemicsen_US
dc.subjectPneumoniaen_US
dc.subjectAustraliaen_US
dc.subjectNew Zealanden_US
dc.subjectPractice Guidelines as Topicen_US
dc.subjectSARS-CoV-2en_US
dc.titleNutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealanden_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.aucc.2020.06.002-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Sites:Gold Coast Health Publications
Show simple item record

Page view(s)

110
checked on Nov 22, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.